Last Updated: September 24, 2026

Litigation Details for CVS PHARMACY, INC. v. ABBVIE, INC. (E.D. Pa. 2018)

✉ Email this page to a colleague

« Back to Dashboard

CVS PHARMACY, INC. v. ABBVIE, INC. (E.D. Pa. 2018)

Docket	⤷ Start Trial	Date Filed	2018-08-17
Court	District Court, E.D. Pennsylvania	Date Terminated	2019-04-29
Cause	15:2 Antitrust Litigation	Assigned To	Harvey Bartle III
Jury Demand	Plaintiff	Referred To
Patents	6,503,894
Link to Docket	External link to docket

Small Molecule Drugs cited in CVS PHARMACY, INC. v. ABBVIE, INC.

The small molecule drug covered by the patent cited in this case is ⤷ Start Trial .

Details for CVS PHARMACY, INC. v. ABBVIE, INC. (E.D. Pa. 2018)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2018-08-17				External link to document
2018-08-17	1	Complaint	filed the patent application that led to issuance of U.S. Patent No. 6,503,894 (“the ‘894 patent”). … the manufacturer’s patents for accuracy or trustworthiness. In listing patents in the Orange Book, …ANDA applicant for patent infringement. If the brand manufacturer initiates a patent infringement action… AndroGel 1% is protected by the ‘894 patent. That patent is owned by Besins and by Unimed, which … A. The ‘894 Patent Litigation 40. The initial patent application that resulted	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.